Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MICHAEL F CARTER

Allopathic & Osteopathic Physicians Family Medicine

NPI
1427045152
CMS profile
19527
Location
HUNTSVILLE, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$1,799.81

111 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,399.81 110
Honoraria $400.00 1

By paying entity

PY2020 · entire year · sorted by reported total

Page 3 of 3; records 101–111 of 111 matching records. This page contains 11 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MICHAEL F CARTER

NPI 1427045152 · CMS profile ID 19527

Allopathic & Osteopathic Physicians / Family Medicine

HUNTSVILLE, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–111 of 111 matching records. This page contains 11 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1427045152?year=2020&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MICHAEL F CARTER, NPI 1427045152, CMS profile ID 19527. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–111 of 111 matching records. This page contains 11 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1427045152?year=2020&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). MICHAEL F CARTER, NPI 1427045152, CMS profile ID 19527. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–111 of 111 matching records. This page contains 11 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1427045152?year=2020&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
MICHAEL F CARTER, NPI 1427045152, CMS profile ID 19527, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–111 of 111 matching records. This page contains 11 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1427045152?year=2020&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

111 matching records · $1,799.81 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 111 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–111 of 111.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Takeda Pharmaceuticals U.S.A., Inc. $20.0802/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747142443 CMS
AstraZeneca Pharmaceuticals LP $11.2802/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736027041 CMS
Novo Nordisk Inc $5.3702/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744604937 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $11.8002/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 737501461 CMS
Amarin Pharma Inc. $17.4402/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739979983 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.0402/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720465893 CMS
Kowa Pharmaceuticals America, Inc. $11.2202/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 716757411 CMS
AstraZeneca Pharmaceuticals LP $13.6701/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736426403 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $12.5101/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 720465899 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.5501/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747142441 CMS
PFIZER INC. $10.9501/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743575155 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,013.07 70
PY2020 $1,799.81 111
PY2021 $1,388.38 117
PY2022 $1,294.96 95
PY2023 $1,056.76 79
PY2024 $1,255.47 87
PY2025 $1,589.34 95

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $809,946.88 27
PY2024 Principal investigator $496,445.23 36
PY2023 Principal investigator $1,186,217.48 55
PY2022 Principal investigator $861,065.31 47
PY2021 Principal investigator $14,287.70 6
PY2020 Principal investigator $1,158.30 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

27 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ModernaTX, Inc. $18,071.10 12/17/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults No dispute reported 06/30/2026 1252968457
Principal investigator 1 PFIZER INC. $1,053.00 12/08/2025 Non-covered Recipient Entity
Research Center Medical Affiliated
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED CLINICAL STUDY EVALUATING THE SAFETY TOLERABILITY IMMUNOGENICITY AND EFFICACY OF A VARIANTADAPTED BNT162B2 VACCINE IN HEALTHY PARTICIPANTS 50 THROUGH 64 YEARS OF AGE No dispute reported 06/30/2026 1228723896
Principal investigator 1 ModernaTX, Inc. $20,678.33 11/03/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults No dispute reported 06/30/2026 1252968451
Principal investigator 1 ModernaTX, Inc. $36,891.63 09/17/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH CENTER INC
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults No dispute reported 06/30/2026 1252968455
Principal investigator 1 ModernaTX, Inc. $55,019.36 08/13/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH CENTER INC
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults No dispute reported 06/30/2026 1252968449
Principal investigator 1 ModernaTX, Inc. $9,688.70 08/06/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH CENTER INC
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults No dispute reported 06/30/2026 1252968445
Principal investigator 1 ModernaTX, Inc. $80,777.51 07/18/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH CENTER INC
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults No dispute reported 06/30/2026 1252968443
Principal investigator 1 PFIZER INC. $406.23 07/08/2025 Non-covered Recipient Entity
Med Affiliated Research Ctr
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 1228707237
Principal investigator 1 PFIZER INC. $476.19 07/08/2025 Non-covered Recipient Entity
Med Affiliated Research Ctr
A PHASE 3 STUDY TO EVALUATE THE EFFICACY IMMUNOGENICITY AND SAFETY OF RESPIRATORY SYNCYTIAL VIRUS RSV PREFUSION F SUBUNIT VACCINE IN ADULTS No dispute reported 06/30/2026 1228707239
Principal investigator 1 ModernaTX, Inc. $26,109.28 06/25/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH CENTER INC
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults No dispute reported 06/30/2026 1252968439
Principal investigator 1 ModernaTX, Inc. $111,084.94 06/04/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH CENTER INC
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults No dispute reported 06/30/2026 1252968453
Principal investigator 1 PFIZER INC. $8,620.40 05/19/2025 Non-covered Recipient Entity
Medical Affiliated Research Center
A PHASE 3 MULTICENTER PARALLELGROUP OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH HERPES ZOSTER SUBUNIT VACCINE IN ADULTS 50 YEARS OF AGE No dispute reported 06/30/2026 1228756665
Principal investigator 1 PFIZER INC. $8,620.40 05/19/2025 Non-covered Recipient Entity
Medical Affiliated Research Center
A PHASE 3 MULTICENTER PARALLELGROUP OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH HERPES ZOSTER SUBUNIT VACCINE IN ADULTS 50 YEARS OF AGE No dispute reported 06/30/2026 1228770507
Principal investigator 1 ModernaTX, Inc. $65,899.20 05/14/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH CENTER INC
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults No dispute reported 06/30/2026 1252968459
Principal investigator 1 IBSA Institut Biochimique SA $3,300.00 05/06/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH CENTER
A multi-center, prospective, randomized, double-blind, flexible-dose, placebo-controlled, parallel group clinical trial of Sildenafil oral film 25 mg, 50 mg, 75 mg and 100 mg for the treatment of erectile dysfunction (ED) No dispute reported 06/30/2026 1223438801
Principal investigator 1 IBSA Institut Biochimique SA $884.25 05/06/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH CENTER
A multi-center, prospective, randomized, double-blind, flexible-dose, placebo-controlled, parallel group clinical trial of Sildenafil oral film 25 mg, 50 mg, 75 mg and 100 mg for the treatment of erectile dysfunction (ED) No dispute reported 06/30/2026 1223438803
Principal investigator 1 PFIZER INC. $426.60 04/28/2025 Non-covered Recipient Entity
Medical Affiliated Research Center
A PHASE 3 MULTICENTER PARALLELGROUP OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH HERPES ZOSTER SUBUNIT VACCINE IN ADULTS 50 YEARS OF AGE No dispute reported 06/30/2026 1228707313
Principal investigator 1 ModernaTX, Inc. $83,795.28 04/23/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH CENTER INC
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults No dispute reported 06/30/2026 1252968441
Principal investigator 1 PFIZER INC. $3,448.16 04/14/2025 Non-covered Recipient Entity
Medical Affiliated Research Center
A PHASE 3 MULTICENTER PARALLELGROUP OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH HERPES ZOSTER SUBUNIT VACCINE IN ADULTS 50 YEARS OF AGE No dispute reported 06/30/2026 1228742851
Principal investigator 1 PFIZER INC. $3,448.16 04/14/2025 Non-covered Recipient Entity
Medical Affiliated Research Center
A PHASE 3 MULTICENTER PARALLELGROUP OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH HERPES ZOSTER SUBUNIT VACCINE IN ADULTS 50 YEARS OF AGE No dispute reported 06/30/2026 1228770472
Principal investigator 1 ModernaTX, Inc. $242,946.66 04/04/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH CENTER INC
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults No dispute reported 06/30/2026 1252968447
Principal investigator 1 PFIZER INC. $10,775.50 03/26/2025 Non-covered Recipient Entity
Medical Affiliated Research Center
A PHASE 3 MULTICENTER PARALLELGROUP OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH HERPES ZOSTER SUBUNIT VACCINE IN ADULTS 50 YEARS OF AGE No dispute reported 06/30/2026 1228742848
Principal investigator 1 PFIZER INC. $10,775.50 03/26/2025 Non-covered Recipient Entity
Medical Affiliated Research Center
A PHASE 3 MULTICENTER PARALLELGROUP OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH HERPES ZOSTER SUBUNIT VACCINE IN ADULTS 50 YEARS OF AGE No dispute reported 06/30/2026 1228760161
Principal investigator 1 PFIZER INC. $1,279.80 03/17/2025 Non-covered Recipient Entity
Medical Affiliated Research Center
A PHASE 3 MULTICENTER PARALLELGROUP OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH HERPES ZOSTER SUBUNIT VACCINE IN ADULTS 50 YEARS OF AGE No dispute reported 06/30/2026 1228707315
Principal investigator 1 PFIZER INC. $793.65 03/17/2025 Non-covered Recipient Entity
Medical Affiliated Research Center
A PHASE 3 MULTICENTER PARALLELGROUP OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH HERPES ZOSTER SUBUNIT VACCINE IN ADULTS 50 YEARS OF AGE No dispute reported 06/30/2026 1228774494
Principal investigator 1 PFIZER INC. $677.05 03/17/2025 Non-covered Recipient Entity
Medical Affiliated Research Center
A PHASE 3 MULTICENTER PARALLELGROUP OPENLABEL STUDY TO EVALUATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH HERPES ZOSTER SUBUNIT VACCINE IN ADULTS 50 YEARS OF AGE No dispute reported 06/30/2026 1228775007
Principal investigator 1 Janssen Research & Development, LLC $4,000.00 01/09/2025 Non-covered Recipient Entity
MEDICAL AFFILIATED RESEARCH CENTER
A Phase 3 Randomized Double-blind Controlled Study to Evaluate the Immunogenicity, Safety, and Reactogenicity of ExPEC9V and High-dose Quadrivalent Influenza Vaccine, With and Without Co-administration, in Adults Aged 65 Years or Older No dispute reported 06/30/2026 1175397218